Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Arsanis' ASN-100 receives FDA fast track designation

Dec. 2, 2016

Roche patent describes TLR7 agonists for HBV infections

Dec. 1, 2016

Tangrun Pharmaceuticals patents agents for HCV infection

Dec. 1, 2016

MicuRx Pharmaceuticals begins phase I study of MRX-4

Dec. 1, 2016

BiondVax's universal flu vaccine safe, well tolerated in phase II study

Dec. 1, 2016

A tetravalent vaccine candidate against lymphatic filariasis

Dec. 1, 2016

Walter Reed Army Institute of Research presents promising new malaria vaccine candidates

Nov. 30, 2016

Hetero Research Foundation patents antiviral agents

Nov. 29, 2016

Janssen initiates phase IIb study of simeprevir, odalasvir and AL-335 for HCV

Nov. 29, 2016

AiCuris conducting new preclinical study of AIC-649 with support from NIAID

Nov. 25, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...